• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[乳腺癌初次治疗后的早期复发:临床病理及影像学预测因素分析]

[Early Recurrence of Breast Cancer after the Primary Treatment: Analysis of Clinicopathological and Radiological Predictive Factors].

作者信息

Yun Sun Geun, An Yeong Yi, Kim Sung Hun, Kang Bong Joo

出版信息

Taehan Yongsang Uihakhoe Chi. 2020 Mar;81(2):395-408. doi: 10.3348/jksr.2020.81.2.395. Epub 2020 Feb 18.

DOI:10.3348/jksr.2020.81.2.395
PMID:36237380
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9431821/
Abstract

PURPOSE

To evaluate the value of clinicopathologic factors and imaging features of primary breast cancer in predicting early recurrence after the primary treatment.

MATERIALS AND METHODS

We enrolled 480 patients who had been followed-up after breast-conserving surgery and adjuvant therapy from January 2010 to December 2014 at our hospital. Early recurrence was defined as recurrence within 3 years after completion of primary treatment, and univariate and multivariate logistic regression analyses were performed to determine the clinicopathologic and imaging predictive factors of early recurrence.

RESULTS

In the univariate analysis, among the clinicopathologic factors, advanced stage ( = 0.021), high histologic grade ( < 0.001), estrogen receptor negative ( = 0.002), high Ki-67 proliferation index ( = 0.017), and triple-negative breast cancer ( = 0.019), and among the imaging features, multifocality ( < 0.001), vessels in the rim on Doppler ultrasonography (US) ( = 0.012), and rim enhancement ( < 0.001) on magnetic resonance imaging of the breast were significantly associated with early recurrence. In the multivariate analysis, advanced stage [odds ratio (OR) = 3.47; 95% confidence interval (CI) 1.12-10.73; = 0.031] and vessels in the rim on Doppler US (OR = 3.32; 95% CI 1.38-8.02; = 0.008) were the independent predictive factors of early recurrence.

CONCLUSION

Vascular findings in the rim of the primary breast cancer on Doppler US before treatment is a radiologic independent predictive factor of early recurrence after the primary treatment.

摘要

目的

评估原发性乳腺癌的临床病理因素和影像学特征在预测初次治疗后早期复发中的价值。

材料与方法

我们纳入了2010年1月至2014年12月在我院接受保乳手术及辅助治疗后进行随访的480例患者。早期复发定义为初次治疗完成后3年内复发,进行单因素和多因素逻辑回归分析以确定早期复发的临床病理和影像学预测因素。

结果

在单因素分析中,临床病理因素中,晚期(P = 0.021)、高组织学分级(P < 0.001)、雌激素受体阴性(P = 0.002)、高Ki-67增殖指数(P = 0.017)和三阴性乳腺癌(P = 0.019),以及影像学特征中,多灶性(P < 0.001)、多普勒超声(US)边缘血管(P = 0.012)和乳腺磁共振成像上的边缘强化(P < 0.001)与早期复发显著相关。在多因素分析中,晚期[比值比(OR)= 3.47;95%置信区间(CI)1.12 - 10.73;P = 0.031]和多普勒超声边缘血管(OR = 3.32;95% CI 1.38 - 8.02;P = 0.008)是早期复发的独立预测因素。

结论

治疗前多普勒超声显示原发性乳腺癌边缘的血管情况是初次治疗后早期复发的影像学独立预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31d1/9431821/fab1af88044d/jksr-81-395-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31d1/9431821/fab1af88044d/jksr-81-395-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31d1/9431821/fab1af88044d/jksr-81-395-g001.jpg

相似文献

1
[Early Recurrence of Breast Cancer after the Primary Treatment: Analysis of Clinicopathological and Radiological Predictive Factors].[乳腺癌初次治疗后的早期复发:临床病理及影像学预测因素分析]
Taehan Yongsang Uihakhoe Chi. 2020 Mar;81(2):395-408. doi: 10.3348/jksr.2020.81.2.395. Epub 2020 Feb 18.
2
Triple-negative breast cancer: Pretreatment magnetic resonance imaging features and clinicopathological factors associated with recurrence.三阴性乳腺癌:与复发相关的预处理磁共振成像特征和临床病理因素。
Magn Reson Imaging. 2020 Feb;66:36-41. doi: 10.1016/j.mri.2019.10.001. Epub 2019 Nov 28.
3
Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.用于指导早期乳腺癌女性辅助化疗决策的基因表达谱分析:基于证据的经济分析
Ont Health Technol Assess Ser. 2010;10(23):1-57. Epub 2010 Dec 1.
4
Predicting local recurrence following breast-conserving treatment: parenchymal signal enhancement ratio (SER) around the tumor on preoperative MRI.保乳治疗后局部复发的预测:术前MRI上肿瘤周围实质信号增强率(SER)
Acta Radiol. 2013 Sep;54(7):731-8. doi: 10.1177/0284185113483676. Epub 2013 Apr 30.
5
Association of mammography and ultrasound features with MammaPrint in patients with estrogen receptor-positive, HER2-negative, node-positive invasive breast cancer.雌激素受体阳性、HER2 阴性、淋巴结阳性浸润性乳腺癌患者的乳腺 X 线摄影和超声特征与 MammaPrint 的相关性。
Acta Radiol. 2021 Dec;62(12):1592-1600. doi: 10.1177/0284185120980003. Epub 2020 Dec 10.
6
Immunohistochemical Subtypes of Breast Cancer: Correlation with Clinicopathological and Radiological Factors.乳腺癌的免疫组织化学亚型:与临床病理及放射学因素的相关性
Iran J Radiol. 2016 Jul 4;13(4):e31386. doi: 10.5812/iranjradiol.31386. eCollection 2016 Oct.
7
Early Stage Triple-Negative Breast Cancer: Imaging and Clinical-Pathologic Factors Associated with Recurrence.早期三阴性乳腺癌:与复发相关的影像学和临床病理因素。
Radiology. 2016 Feb;278(2):356-64. doi: 10.1148/radiol.2015150089. Epub 2015 Jul 31.
8
Radiomics features based on automatic segmented MRI images: Prognostic biomarkers for triple-negative breast cancer treated with neoadjuvant chemotherapy.基于自动分割 MRI 图像的放射组学特征:新辅助化疗治疗三阴性乳腺癌的预后生物标志物。
Eur J Radiol. 2022 Jan;146:110095. doi: 10.1016/j.ejrad.2021.110095. Epub 2021 Dec 4.
9
Association between rim enhancement of breast cancer on dynamic contrast-enhanced MRI and patient outcome: impact of subtype.动态对比增强磁共振成像中乳腺癌边缘强化与患者预后的关系:亚型的影响
Breast Cancer Res Treat. 2014 Dec;148(3):541-51. doi: 10.1007/s10549-014-3170-9. Epub 2014 Nov 7.
10
Dynamic contrast-enhanced and diffusion-weighted MRI of invasive breast cancer for the prediction of sentinel lymph node status.浸润性乳腺癌的动态对比增强和扩散加权磁共振成像用于预测前哨淋巴结状态。
J Magn Reson Imaging. 2020 Feb;51(2):615-626. doi: 10.1002/jmri.26865. Epub 2019 Jul 16.

本文引用的文献

1
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
2
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
3
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015.韩国癌症统计数据:2015 年发病率、死亡率、生存率和流行率。
Cancer Res Treat. 2018 Apr;50(2):303-316. doi: 10.4143/crt.2018.143. Epub 2018 Mar 21.
4
Association of preoperative breast MRI features with locoregional recurrence after breast conservation therapy.保乳治疗后术前乳腺MRI特征与局部区域复发的相关性
Acta Radiol. 2018 Apr;59(4):409-417. doi: 10.1177/0284185117723041. Epub 2017 Jul 26.
5
Multifocal and Multicentric Breast Carcinoma: A Significantly More Aggressive Tumor than Unifocal Breast Cancer.多灶性和多中心性乳腺癌:一种比单灶性乳腺癌更具侵袭性的肿瘤。
Anticancer Res. 2017 Aug;37(8):4593-4598. doi: 10.21873/anticanres.11858.
6
Basic Facts of Breast Cancer in Korea in 2014: The 10-Year Overall Survival Progress.2014年韩国乳腺癌基本情况:10年总生存率进展
J Breast Cancer. 2017 Mar;20(1):1-11. doi: 10.4048/jbc.2017.20.1.1. Epub 2017 Mar 24.
7
Dynamic contrast-enhanced breast magnetic resonance imaging for the prediction of early and late recurrences in breast cancer.动态对比增强乳腺磁共振成像用于预测乳腺癌的早期和晚期复发
Medicine (Baltimore). 2016 Nov;95(48):e5330. doi: 10.1097/MD.0000000000005330.
8
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.将芳香化酶抑制剂辅助治疗延长至10年。
N Engl J Med. 2016 Jul 21;375(3):209-19. doi: 10.1056/NEJMoa1604700. Epub 2016 Jun 5.
9
Differences in Prognostic Factors between Early and Late Recurrence Breast Cancers.早期和晚期复发乳腺癌预后因素的差异
Asian Pac J Cancer Prev. 2015;16(15):6575-9. doi: 10.7314/apjcp.2015.16.15.6575.
10
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.原发性乳腺癌:ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2015 Sep;26 Suppl 5:v8-30. doi: 10.1093/annonc/mdv298.